David Jin
Fortune : 36 771 $ au 31/05/2026
Fortune : 36 771 $ au 31/05/2026
David K.
Jin is currently President, CEO, Director & Chief Medical Officer at GenExosome Technologies, Inc. since 2017.
Dr. Jin is also Chief Executive Officer & Director at Avalon Heathcare Systems, Inc. Formerly, Dr. Jin was President, Chief Executive Officer & Director at Avalon GloboCare Corp.
from 2016 to 2025.
Dr. Jin served as Chief Medical Officer at AdvisoryCloud, Inc. Dr. Jin was Chief Medical Officer at Lineage Cell Therapeutics, Inc. from 2009 to 2016.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AVALON GLOBOCARE CORP. 0,85 % | 15/04/2026 | 103 000 ( 0,85 % ) | 36 771 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
GenExosome Technologies, Inc.
GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Directeur Général | 27/09/2017 |
Avalon Heathcare Systems, Inc. | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| AVALON GLOBOCARE CORP. | Directeur Général | 30/11/2025 |
| LINEAGE CELL THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2016 |
AdvisoryCloud, Inc.
AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Avalon GloboCare Corp.
Avalon GloboCare Corp. BiotechnologyHealth Technology Provides biotechnology and healthcare service | Health Technology |
AdvisoryCloud, Inc.
AdvisoryCloud, Inc. Miscellaneous Commercial ServicesCommercial Services Provides ranking services for leading executives | Commercial Services |
GenExosome Technologies, Inc.
GenExosome Technologies, Inc. MiscellaneousMiscellaneous Operates as an investment holding company | Miscellaneous |
Avalon Heathcare Systems, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national